\u00d6d Da\u015f\u0131 X\u0259st\u0259liyinin \u018flam\u0259tl\u0259ri N\u0259l\u0259rdir?<\/h2>\n\n\n\n

\u00d6d da\u015f\u0131 \u0259m\u0259l\u0259 g\u0259lm\u0259y\u0259 ba\u015flayandan sonra da\u015flar\u0131n say\u0131 v\u0259 \u00f6l\u00e7\u00fcs\u00fc artsa da, ad\u0259t\u0259n ilk vaxtlarda \u00f6d kis\u0259si simptomlar\u0131na s\u0259b\u0259b olmur. \u018fks\u0259riyy\u0259ti a\u011fr\u0131s\u0131z olan \u00f6d da\u015flar\u0131 b\u0259zi hallar istisna olmaqla, m\u00fcayin\u0259l\u0259r zaman\u0131 v\u0259 ya b\u0259zi \u0259m\u0259liyyatlar zaman\u0131 t\u0259sad\u00fcf\u0259n a\u015fkarlan\u0131r. \u00d6d da\u015f\u0131 x\u0259st\u0259liyinin gedi\u015find\u0259 da\u015f \u0259sas \u00f6d axar\u0131na d\u00fc\u015f\u0259rs\u0259, \u00e7ox daha problemli bir proses\u0259 \u00e7evrilir. Obstruktiv sar\u0131l\u0131q adlanan bu prosesd\u0259 x\u0259st\u0259d\u0259 qar\u0131n a\u011fr\u0131s\u0131, sar\u0131l\u0131q, sidiyin q\u0131rm\u0131z\u0131 v\u0259 ya q\u0259hv\u0259yi r\u0259ngd\u0259 olmas\u0131, \u00fcr\u0259kbulanma, qusma v\u0259 b\u0259z\u0259n q\u0131zd\u0131rma kimi \u0259lam\u0259tl\u0259r m\u00fc\u015fahid\u0259 oluna bil\u0259r. <\/p>\n\n\n\n

Bununla yana\u015f\u0131, da\u015f \u00f6d axar\u0131n\u0131 ba\u011flad\u0131qda meydana g\u0259l\u0259n \u00f6d kis\u0259si x\u0259st\u0259liyinin \u0259lam\u0259tl\u0259rini a\u015fa\u011f\u0131dak\u0131 kimi \u00fcmumil\u0259\u015fdirm\u0259k olar:<\/p>\n\n\n\n

• Qar\u0131n\u0131n yuxar\u0131 sa\u011f nahiy\u0259sind\u0259 q\u0259fil v\u0259 s\u00fcr\u0259tl\u0259 a\u011f\u0131rla\u015fan a\u011fr\u0131<\/li>
• K\u00fcr\u0259k v\u0259 bel a\u011fr\u0131s\u0131<\/li>
• Sa\u011f \u00e7iyind\u0259 a\u011fr\u0131<\/li>
• \u00dcr\u0259kbulanma v\u0259 qusma<\/li>
• Sidik r\u0259nginin qaralmas\u0131<\/li>
• H\u0259ddind\u0259n art\u0131q qaz v\u0259 dig\u0259r h\u0259zm probleml\u0259ri<\/li>
• \u0130shal<\/li><\/ul>\n\n\n\n

  <\/figure>\n\n\n\n

  \u00d6d Da\u015f\u0131 X\u0259st\u0259liyinin M\u00fcalic\u0259si Nec\u0259 Olmal\u0131d\u0131r?<\/h2>\n\n\n\n

  X\u0259st\u0259liyin v\u0259 onun a\u011f\u0131rla\u015fmalar\u0131n\u0131n m\u00fcalic\u0259sind\u0259 m\u00fcxt\u0259lif \u00fcsullardan istifad\u0259 edilir. \u018fn \u00e7ox istifad\u0259 edil\u0259n \u00fcsul laparoskopik c\u0259rrahiyy\u0259dir. \u00d6d kis\u0259si \u0259m\u0259liyyatlar\u0131n\u0131n 5%-d\u0259n az hiss\u0259si a\u00e7\u0131q \u0259m\u0259liyyatla h\u0259yata ke\u00e7irilir. ERCP v\u0259 PTK laz\u0131m olduqda istifad\u0259 edil\u0259n dig\u0259r m\u00fcalic\u0259 \u00fcsullar\u0131d\u0131r. \u00d6d da\u015f\u0131n\u0131n m\u00fcalic\u0259si \u00fc\u00e7\u00fcn \u00f6d kis\u0259sinin \u00e7\u0131xar\u0131lmas\u0131na xolesistektomiya deyilir. Q\u0131z\u0131l standart xolesistektomiya yana\u015fmas\u0131 laparoskopik \u0259m\u0259liyyatlard\u0131r. \u018fg\u0259r \u0259m\u0259liyyat m\u00fcxt\u0259lif s\u0259b\u0259bl\u0259rd\u0259n laparoskopik \u00fcsulla h\u0259yata ke\u00e7irilmirs\u0259, a\u00e7\u0131q \u0259m\u0259liyyat \u00fcsuluna \u00fcst\u00fcnl\u00fck veril\u0259 bil\u0259r. <\/p>\n\n\n\n

  Bu g\u00fcn c\u0259rrahi \u0259m\u0259liyyat zaman\u0131 kis\u0259ni t\u0259rk etm\u0259k v\u0259 yaln\u0131z da\u015flar\u0131 \u00e7\u0131xarmaq rasional yana\u015fma kimi q\u0259bul edilir. Bunun s\u0259b\u0259bi x\u0259st\u0259l\u0259rd\u0259 t\u0259xmin\u0259n 1 il \u0259rzind\u0259 da\u015flar\u0131n t\u0259krarlanma v\u0259 a\u011f\u0131rla\u015fma riskidir. \u00dcmumi anesteziya alt\u0131nda apar\u0131lan laparoskopik xolesistektomiya \u0259m\u0259liyyat\u0131nda operator x\u0259st\u0259nin qarn\u0131nda 3-4 k\u0259sik edir. Bu k\u0259sik yerl\u0259rind\u0259n x\u0259st\u0259nin qar\u0131n bo\u015flu\u011funa ki\u00e7ik v\u0259 i\u015f\u0131ql\u0131 c\u0259rrahi al\u0259tl\u0259r daxil edilir v\u0259 \u00f6d kis\u0259si \u00e7\u0131xar\u0131l\u0131r. X\u0259st\u0259l\u0259r \u0259m\u0259liyyatdan sonra bir m\u00fcdd\u0259t m\u00fc\u015fahid\u0259 edilir v\u0259 arzuolunmaz bir v\u0259ziyy\u0259tl\u0259 rastla\u015fmazsa eyni g\u00fcn v\u0259 ya \u0259m\u0259liyyatdan sonrak\u0131 g\u00fcn ev\u0259 burax\u0131la bil\u0259rl\u0259r.<\/p>\n\n\n\n

  <\/figure>\n\n\n\n

  \u00d6d kis\u0259si da\u015flar\u0131na c\u0259rrahi m\u00fcdaxil\u0259nin xaricind\u0259 tibbi m\u00fcalic\u0259 v\u0259 litotripsi adl\u0131 \u00fcsulla m\u00fcdaxil\u0259 edil\u0259 bil\u0259r. \u018fm\u0259liyyat oluna bilm\u0259y\u0259n insanlarda x\u00fcsusil\u0259 xolesterinin s\u0259b\u0259b oldu\u011fu da\u015flarda ursodiol aktiv madd\u0259si olan d\u0259rmanlar t\u0259tbiq oluna bil\u0259r. Bu d\u0259rmanlar\u0131n g\u00fcnd\u0259 2-4 d\u0259f\u0259 m\u00fcxt\u0259lif dozalarda q\u0259bul edilm\u0259si \u00f6d kis\u0259sind\u0259 da\u015flar\u0131n ke\u00e7m\u0259sinin ill\u0259r \u00e7\u0259k\u0259 bil\u0259c\u0259yi, m\u00fcalic\u0259nin k\u0259silm\u0259sind\u0259n sonra x\u0259st\u0259l\u0259rd\u0259 yenid\u0259n da\u015f \u0259m\u0259l\u0259 g\u0259lm\u0259sinin m\u00fc\u015fahid\u0259 oluna bilm\u0259si kimi probleml\u0259rl\u0259 qar\u015f\u0131la\u015fa bil\u0259r. <\/p>\n\n\n\n

  \u00d6d da\u015f\u0131n\u0131n simptomlar\u0131 v\u0259 dig\u0259r \u015fikay\u0259tl\u0259r zaman ke\u00e7dikc\u0259 g\u00f6r\u00fcn\u0259 v\u0259 sonra yox ola bil\u0259r. X\u00fcsusil\u0259 5 saatdan \u00e7ox davam ed\u0259n qar\u0131n a\u011fr\u0131s\u0131ndan \u015f\u0131ikay\u0259t edirsinizs\u0259, sar\u0131l\u0131q \u0259lam\u0259tl\u0259ri m\u00fc\u015fayi\u0259t olunursa, n\u0259cis a\u011f r\u0259ngd\u0259dirs\u0259 v\u0259 bu \u0259lam\u0259tl\u0259r bu kimi dig\u0259r \u015fikay\u0259tl\u0259rl\u0259 m\u00fc\u015fayi\u0259t olunursa, bu zaman s\u0259hiyy\u0259 m\u00fc\u0259ssis\u0259l\u0259rin\u0259 m\u00fcraci\u0259t etm\u0259yiniz t\u00f6vsiy\u0259 olunur. <\/p>\n\n

  <\/div>","protected":false},"excerpt":{"rendered":"

  \u00d6d kis\u0259si qar\u0131n bo\u015flu\u011funun yuxar\u0131 sa\u011f nahiy\u0259sind\u0259 qaraciy\u0259rin bir az alt\u0131nda yerl\u0259\u015f\u0259n armud formal\u0131 orqand\u0131r. Ba\u011f\u0131rsaqlara ifraz etdiyi sar\u0131-ya\u015f\u0131l \u00f6d il\u0259 orqanizmin h\u0259zm funksiyalar\u0131na \u0259h\u0259miyy\u0259tli d\u0259r\u0259c\u0259d\u0259 t\u00f6hf\u0259 verir. \u00d6d kis\u0259sind\u0259 da\u015f\u0131n \u0259m\u0259l\u0259 g\u0259lm\u0259si, \u00f6d da\u015f\u0131 x\u0259st\u0259liyi olaraq t\u0259yin olunur v\u0259 ad\u0259t\u0259n x\u0259st\u0259lik ya\u015fla art\u0131r. H\u0259zm\u0259 k\u00f6m\u0259k ed\u0259n \u00f6d \u00e7ox y\u00fcks\u0259k s\u0259viyy\u0259d\u0259 xolesterin ehtiva edir v\u0259… \u018ftrafl\u0131 \u00bb\u00d6d Da\u015f\u0131 X\u0259st\u0259liyi N\u0259dir? X\u0259st\u0259liyin Simptomlar\u0131 v\u0259 M\u00fcalic\u0259 \u00dcsullar\u0131 N\u0259dir?<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":674,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","neve_meta_reading_time":"","_ti_tpc_template_sync":false,"_ti_tpc_template_id":"","footnotes":""},"categories":[517],"tags":[1005,1016,1011,1015,1022,1013,1008,1009,1020,1018,1025,1006,1026,1017,1012,1027,1023,1014,1007,1010,1024,1021,1019],"yoast_head":"\n